
More athletes are turning to regenerative medicine for athletes as a way to treat sports injuries without the downtime, risk,...


Availability depends on how the cells are processed. PRP therapy, a minimally manipulated treatment made from a patient’s own blood, is available through private regenerative treatment Belfast clinics. Cultured or expanded stem cell products are classified as Advanced Therapy Medicinal Products (ATMPs) under UK law and are not lawfully available outside an MHRA-authorised trial or licensed product.
If you have searched for stem cell therapy Northern Ireland, the results can be confusing. Some clinics use “stem cell” loosely to describe same-day PRP injections. Others reference treatments that would legally need a UK marketing authorisation before being offered commercially at all.
This article separates the two, and explains what UK law says about each.
Skip the searching and get a straight answer. Book a consultation with the Medica Stem Cells clinical team in Belfast.
Regenerative medicine Belfast clinics offer is a category of treatment that uses a patient’s own blood or tissue-derived cells to support the body’s natural repair process, rather than replacing damaged tissue surgically. It includes platelet-rich plasma (PRP) therapy and other cell-based injections used for joint and soft tissue conditions.
The legal distinction that matters most is how much the cells are processed before use.
An ATMP is a cell or tissue-based treatment that has been substantially manipulated, such as through laboratory culturing or expansion. Under UK law, ATMPs are regulated as medicines. They require a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) before they can be sold or administered commercially.
This is the central legal fact that most stem cell clinic Belfast searches do not surface clearly. If a treatment involves cells that have been cultured or expanded outside the body, it is legally a medicine, not a procedure. It cannot be lawfully marketed or administered commercially in the UK unless it holds an MHRA marketing authorisation, or is being delivered within an MHRA-authorised clinical trial.
Regulation 279 of the Human Medicines Regulations 2012 also prohibits advertising an unlicensed medicine. An academic review of UK commercial stem cell clinics found some had advertised unlicensed cell therapies despite this restriction, with inconsistent oversight across regulators. This is a genuine compliance risk in this sector, not a hypothetical one.
PRP therapy sits on the other side of this line. Because it is minimally manipulated and used on the same day it is collected, it is generally treated as a clinical procedure rather than a medicinal product. This is consistent with how the National Institute for Health and Care Excellence (NICE) reviewed PRP for knee osteoarthritis, as an interventional procedure, not a licensed medicine.
The Human Tissue Authority (HTA) also has a role. It licenses establishments that procure, process, or store tissues and cells intended as starting material for an ATMP. A clinic offering genuine cell-based treatments involving any laboratory processing should be able to show relevant HTA licensing for that activity.
In practice, this means PRP therapy is the treatment most private regenerative medicine Belfast clinics can lawfully offer as a standard, same-day service. It is used for joint pain, arthritis treatment Belfast cases, and sports injury treatment Belfast presentations, without requiring cells to be cultured or expanded.
Any independent clinic delivering these treatments in Northern Ireland should be registered with the Regulation and Quality Improvement Authority (RQIA). This is the body responsible for regulating and inspecting independent clinics and hospitals under the Health and Personal Social Services (Quality, Improvement and Regulation) (Northern Ireland) Order 2003. RQIA registration covers the clinic as a healthcare premises, and is separate from MHRA or HTA requirements for the treatment itself.
PRP, or platelet-rich plasma therapy, concentrates platelets from a patient’s own blood and injects them into an injured or arthritic area. Platelets release growth factors that support tissue repair and reduce inflammation, using the body’s own healing response.
A small blood sample is drawn and spun in a centrifuge to separate a platelet-concentrated layer. This is then injected into the affected joint or tissue, usually as a same-day procedure without general anaesthesia. For a fuller comparison of the two treatment types, see PRP vs Stem Cell Therapy: Which Treatment Is Right for You.
Patient Testimonial
“Just over 1 year since my initial consultation and treatment.. Very happy with the results and outcome so far. Pain free knees since the finish of all treatments.” — F. Connolly, Medica Stem Cells patient (see more patient testimonials)
Clinics offering knee pain treatment Belfast and arthritis treatment Belfast services generally assess candidates based on the joint or tissue involved, the stage of degeneration, and prior treatment history.
Conditions commonly assessed for PRP include:
A typical first assessment includes a review of imaging, symptom history, and any previous treatments such as physiotherapy or corticosteroid injections. A specialist then determines whether PRP is appropriate for that specific joint and stage of wear.
The next step is a proper assessment, not more searching. Book a consultation with Medica Stem Cells Belfast and find out whether PRP is suitable for your joint or injury.
NICE reviewed platelet-rich plasma injections for knee osteoarthritis in interventional procedures guidance IPG637. It found no major safety concerns, but noted that evidence on efficacy is limited in quality. It recommended the procedure only be used with clinical governance, informed consent, and outcome auditing in place.
A separate consensus statement from French-speaking rheumatology and sports medicine experts, developed using the French National Authority for Health methodology, reached a more favourable view. It found that intra-articular PRP injections are an effective symptomatic treatment for early to moderate knee osteoarthritis, rating this recommendation as level of evidence 1A.
Read together, these sources agree on the same practical point. PRP has a reasonable, if mixed-quality, evidence base for early to moderate joint degeneration specifically. It is not a guaranteed fix, and results vary between patients. Medica Stem Cells’ own published research and case studies are available for patients who want to review the underlying data.
Given the regulatory gap described above, a few checks matter more than general reputation:
No. Minimally manipulated treatments like PRP are regulated as procedures. Substantially manipulated or cultured cell products are regulated as medicines and require MHRA marketing authorisation before commercial use.
PRP uses concentrated platelets from a patient's own blood to release growth factors that support healing, with minimal processing. Stem cell therapy, in the strict legal sense, typically involves cells that have been cultured or expanded, which places it under ATMP regulation.
Only if the product holds an MHRA marketing authorisation, or the treatment is delivered within an MHRA-authorised clinical trial. Advertising an unlicensed medicine is restricted under the Human Medicines Regulations 2012.
NICE's interventional procedures guidance on PRP for knee osteoarthritis found no major safety concerns, though it recommended the procedure be delivered with proper clinical governance and outcome monitoring.
Candidacy depends on the joint or tissue involved, the stage of degeneration on imaging, and what treatments you have already tried. A specialist assessment is the only reliable way to know.
Stem cell treatment, in the strict sense of cultured or expanded cell products, is tightly regulated in the UK. It is not something a private clinic can lawfully offer as a routine commercial service. PRP therapy Northern Ireland options, by contrast, use minimally manipulated cells and are available through regulated private clinics for joint pain, arthritis, and sports injuries. If you are researching regenerative treatment Belfast providers, the most useful question is not “do you offer stem cell therapy.” It is “what exactly is being processed, and under what regulatory authorisation.”
Book a consultation with our clinical team at Medica Stem Cells Belfast to discuss your joint or injury.
This article is for informational purposes only and does not constitute medical or legal advice. Individual results may vary. Please consult a qualified clinician before making any treatment decisions, and seek independent legal advice for questions about the regulatory status of a specific treatment.

More athletes are turning to regenerative medicine for athletes as a way to treat sports injuries without the downtime, risk,...

More athletes are turning to regenerative medicine for athletes as a way to treat sports injuries without the downtime, risk,...

If you are living with ongoing knee pain and facing the prospect of surgery, you may be wondering whether stem...

If you have searched for a stem cell clinic in Ireland, you are probably weighing up an option your GP...

Thank you {{_full_name}}!
We will be in contact with you shortly.